ABT Stock: Abbott Laboratories Trades Near 52-Week Low as Shares Attempt a Modest Bounce
By TrendSpider Editor
Abbott Laboratories edged higher by 0.30% on Thursday, March 26, 2026, with shares currently trading at $105.14, just above yesterday's session low of $102.41, which also marks the stock's 52-week low. The attempted recovery comes after a bruising stretch that has left ABT trading well below its 52-
ABT Stock: Abbott Laboratories Trades Near 52-Week Low as Shares Attempt a Modest Bounce
Abbott Laboratories edged higher by 0.30% on Thursday, March 26, 2026, with shares currently trading at $105.14, just above yesterday's session low of $102.41, which also marks the stock's 52-week low. The attempted recovery comes after a bruising stretch that has left ABT trading well below its 52-week high of $139.05, representing a drawdown of roughly 24% from peak levels. With the stock pinned near multi-year support, traders are watching closely to see whether this floor holds or gives way entirely.
Key Drivers of the ABT Stock Move
- Main Catalyst: ABT is trading in proximity to its 52-week low of $102.41, which was touched during yesterday's session. The stock's current price of $105.14 represents only a slim buffer above that key technical level, making the current zone a critical battleground between buyers and sellers.
- Bull Case: Thursday's modest gain of 0.30% suggests some stabilization is occurring directly at what is now a clearly defined support zone at $102.41. Buyers willing to step in at or near the 52-week low may view current prices as a value entry relative to the $139.05 high reached over the past year.
- Bear Case: The broader trend has been unambiguously negative. Yesterday's trading range ran from $102.41 to $104.25, meaning the stock spent the prior session almost entirely below today's current price, reflecting persistent selling pressure. A decisive break below $102.41 would establish a new 52-week low and could accelerate downside momentum with no established technical support beneath that level.
The forward setup for Abbott hinges entirely on whether the $102.41 level can serve as a durable floor. The stock's position near the bottom of its 52-week range signals that the market has been consistently repricing ABT lower over an extended period, and a single day of modest gains does not yet constitute a reversal. Traders will want to see the stock build a base with multiple sessions of higher lows before drawing any conclusions about a sustainable turn. Volume confirmation on any upside follow-through would be a key signal to watch in the sessions ahead.
ABT Seasonality
Late March historically represents a transitional period for large-cap healthcare names, as investors begin positioning ahead of first-quarter earnings season. For a company like Abbott, which reports across multiple business segments including diagnostics and medical devices, this window can bring increased volatility as expectations are reset heading into the Q1 reporting cycle.
ABT Relative Performance
At $105.14, Abbott is trading just 2.66% above its 52-week low of $102.41 and approximately 24.4% below its 52-week high of $139.05. Yesterday's session range of $102.41 to $104.25 indicates that the stock is attempting to reclaim ground above recent session highs, but the gap between current prices and the 52-week high reflects significant underperformance relative to where the stock was trading earlier in the trailing twelve-month period. Investors comparing ABT to broader healthcare sector peers will note that a stock trading near annual lows stands in contrast to any peers that have managed to hold closer to their respective highs during the same timeframe.